查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1715685

尿道結石管理設備市場（按設備類型、治療類型、設備材料、應用和最終用戶分類）—2025 年至 2030 年全球預測

Urolithiasis Management Devices Market by Device Type, Treatment Type, Device Material, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2024 年尿道結石管理設備市場規模將達到 4.9076 億美元，到 2025 年將達到 5.2703 億美元，到 2030 年將達到 7.673 億美元，複合年成長率為 7.73%。

主要市場統計數據
基準年2024年 4.9076億美元
預計2025年 5.2703億美元
預測年份 2030 7.673億美元
複合年成長率（%） 7.73%

目前，尿道結石管理設備領域正處於技術快速創新和轉型的時期。在當今的醫療保健環境中，技術進步促進了設備的開發，使得治療腎結石、輸尿管結石和膀胱結石的設備更加精確、高效和安全。這個充滿活力的領域將複雜的醫學工程與不斷發展的臨床實踐相結合，以解決最常見的泌尿道疾病之一。

包括臨床醫生、生物醫學工程師和醫院管理人員在內的相關人員一直在尋找不僅可以改善病患治療效果而且可以減少手術併發症的解決方案。先進影像技術、微創介入技術和改進的人體工學設備的整合極大地改變了結石管理的實踐。這種演變代表著一種漸進的轉變，其中傳統方法正在被旨在透過內視鏡和非侵入性方法治療尿道結石的最先進的設備所補充甚至取代。

在這種環境下，專家的洞察力和基於證據的數據指南決策並推動研發投資。隨著技術創新不斷顛覆傳統方法，臨床效果與技術進步之間的相互作用將決定未來策略的藍圖。利用這些改進來增強臨床工作流程和患者照護的機會比以往任何時候都更加突出，這表明整個市場前景光明。

推動尿道結石市場變革

近年來，我們看到了重新定義尿道結石管理設備市場的變革性變化。技術創新的步伐正在引領設備不僅更有效率，而且更加安全、易於使用。技術創新帶來了影像的改善、導航能力的增強以及手術過程中的即時回饋機制。這種演變的部分原因是人們對微創手術的需求不斷增加、患者舒適度提高和恢復時間縮短。

監管政策也在不斷發展，以促進創新醫療設備更快進入市場，同時仍優先考慮病患安全。臨床醫生和技術專家之間的合作努力正在引領針對尿道結石治療細節的設備的開發。醫療保健提供者現在擴大採用與現有醫院基礎設施無縫整合的技術，並透過自動化和數位監控簡化複雜的程序。

此外，市場正在逐漸從傳統的手術方法轉向結合基於人工智慧的診斷和程序指導的數位技術。隨著業界認知到這些新設備尚未開發的潛力，研發投資持續穩定成長。這種不斷變化的格局由不斷發展的生態系統所支撐，該生態系統將創新與可操作的、基於證據的臨床結果相結合。透過臨床醫生和醫療設備製造商之間的協同效應，改善患者治療效果和提高成本效率正在迅速成為現實。

深入市場區隔：深入了解設備、治療、材料、應用和最終用戶

對尿道結石管理設備市場的全面分析揭示了一種複雜的細分策略，可以捕捉市場格局的多樣性。根據設備類型進行細分，將市場分為導管導引線、碎石機、支架、輸尿管鏡等部分，每個部分在治療通訊協定中都發揮獨特的作用。從治療類型的角度來看市場，很明顯體外震波碎石術、腔內碎石術和經皮腎鏡碎石術是首選的治療方法，每種治療方法在侵入性和恢復時間方面都具有明顯的優勢。

透過根據設備材料進行細分，將市場分為基於金屬的設備和基於聚合物的設備，進一步豐富了分析。這種分類有助於了解影響治療結果的性能、耐用性和患者特定考慮因素方面的差異。此外，透過關注基於應用的分類，市場研究涵蓋了與膀胱結石、腎結石和輸尿管結石相關的病理，從而提供了針對治療需求和外科專業的客製化視圖。

市場區隔的另一個方面著重於最終用戶，包括門診手術中心、醫院和專科診所。這種細分策略觀點可以更深入地了解市場需求、收購趨勢以及每個最終用戶類別的獨特要求。這些不同部分的相互作用有助於全面了解當前的市場動態，確保從技術創新到臨床應用的所有方面都納入整體評估中。對於尋求在競爭激烈且快速發展的環境中製定策略的相關人員來說，這種細緻的框架至關重要。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 尿道結石發生率不斷上升，老齡人口不斷增加
      • 非侵入性手術的趨勢和對微創技術的認知日益增強
      • 醫院領域擴大採用創新技術
    • 限制因素
      • 尿道結石治療設備有限且成本高昂
    • 機會
      • 可攜式、方便用戶使用的尿道結石管理設備的開發
      • 有效治療尿道結石的微創設備技術進步
    • 任務
      • 擔心治療可能產生的副作用
  • 市場區隔分析
    • 設備類型：輸尿管鏡因其在取石方面卓越的視覺和機械性能而越來越受到青睞
    • 應用：拓展尿道結石管理設備在膀胱結石管理的應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章尿道結石管理設備市場（依設備類型）

  • 導管導引線
  • 碎石機
  • 支架
  • 輸尿管鏡

第7章尿道結石管理設備市場（依治療類型）

  • 體外震波碎石術
  • 體內碎石術
  • 經皮腎鏡取石術

第8章尿道結石管理設備市場（依設備材料）

  • 金屬基元件
  • 基於聚合物的設備

第9章尿道結石管理設備市場（依應用）

  • 膀胱結石
  • 腎結石
  • 輸尿管結石

第 10 章尿道結石管理設備市場（依最終用戶）

  • 門診手術中心
  • 醫院
  • 專科診所

11. 美洲尿道結石管理設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12. 亞太地區尿道結石管理設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13. 歐洲、中東和非洲尿道結石管理設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Advanced MedTech Holdings
  • AKSM, Ltd.
  • Avvio Medical, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Calyxo Inc.
  • Coloplast A/S
  • Cook Group Incorporated
  • DirexGroup
  • Dornier MedTech GmbH
  • Dyne Medical Group Inc.
  • EMS Electro Medical Systems SA
  • EDAP TMS SA
  • Elmed Lithotripsy Systems
  • EndoTheia, Inc.
  • Karl Storz GmbH & Co. KG
  • Nissha Medical Technologies
  • Olympus Corporation
  • Quanta System SpA
  • Richard Wolf GmbH
  • Siemens Healthineers
  • SonoMotion
  • Teleflex Incorporated
Product Code: MRR-ED54C46E9009

The Urolithiasis Management Devices Market was valued at USD 490.76 million in 2024 and is projected to grow to USD 527.03 million in 2025, with a CAGR of 7.73%, reaching USD 767.30 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 490.76 million
Estimated Year [2025] USD 527.03 million
Forecast Year [2030] USD 767.30 million
CAGR (%) 7.73%

The current landscape of urolithiasis management devices is witnessing an era of rapid innovation and transformative change. In today's healthcare environment, technological advances have led to the development of devices that offer enhanced precision, efficiency, and safety for the treatment of kidney stones, ureteral stones, and bladder stones. This dynamic field blends intricate medical engineering with evolving clinical practices to address one of the most prevalent urinary tract disorders.

Stakeholders including clinicians, biomedical engineers, and hospital administrators are consistently on the lookout for solutions that not only improve patient outcomes but also reduce procedural complications. The integration of advanced imaging, minimally invasive intervention techniques, and improved device ergonomics has dramatically reshaped practices in stone management. This evolution signifies a progressive shift where traditional methods are being supplemented or even replaced by state-of-the-art devices designed to manage urolithiasis through both endoscopic and non-invasive approaches.

In this environment, expert insights and evidence-based data guide decision-making and foster investments in research and development. As innovation continues to disrupt conventional methods, the interplay between clinical efficacy and technological advancements defines the roadmap for future strategies. The opportunity to leverage these improvements for enhanced clinical workflows and patient care is more pronounced than ever, indicating a promising outlook for the market overall.

Transformative Shifts Driving the Urolithiasis Market

Recent years have been marked by transformative shifts that are redefining the urolithiasis management device market. The pace of technological innovation has ushered in devices that are not only more efficient but also safer and easier to use. Innovations have led to improvements in imaging techniques, enhanced navigation capabilities, and real-time feedback mechanisms during surgeries. This evolution has partly been driven by a growing demand for minimally invasive procedures, improved patient comfort, and reduced recovery times.

Regulatory policies have also evolved, facilitating faster market entry for innovative medical devices while ensuring patient safety remains paramount. Collaborative efforts between clinical practitioners and technical experts have fostered the creation of devices that are increasingly tailored to the nuances of urolithiasis treatment. Healthcare providers are now more inclined to adopt technology that integrates seamlessly with existing hospital infrastructure and simplifies complex procedures through automation and digital oversight.

Furthermore, the market is witnessing a gradual shift from traditional surgical methods to digitally-enhanced techniques that incorporate AI-driven diagnostics and procedural guidance. Investment in research and development continues to flow steadily as industries recognize the untapped potential of these novel devices. The transformation in the landscape is underpinned by an evolving ecosystem that blends innovation with practical, evidence-based clinical outcomes. As clinicians and medical device manufacturers work synergistically, the promise of improved therapeutic outcomes combined with cost-efficiency is rapidly becoming a reality.

Deep Dive: Market Segmentation Insights into Device, Treatment, Material, Application, and End Users

A comprehensive analysis of the urolithiasis management device market reveals an intricate segmentation strategy that captures the diversity of the market landscape. The segmentation based on device type dissects the market into segments that include guidewires, lithotripters, stents, and ureteroscopes, each playing a unique role in the treatment protocol. When the market is examined through the lens of treatment type, it is clear that extracorporeal shock wave lithotripsy, intracorporeal lithotripsy, and percutaneous nephrolithotomy are at the forefront of procedural choices, each offering distinct advantages regarding invasiveness and recovery time.

The analysis is further enriched by segmentation based on device material, categorizing the market into metal-based devices and polymer-based devices. This classification helps in understanding performance differences, durability, and patient-specific considerations that underline treatment efficacy. Moreover, by looking at the application-based categorization, the market study addresses conditions pertaining to bladder stones, kidney stones, and ureteral stones, thereby offering a tailored view of therapeutic needs and operational specialties.

Another dimension of market segmentation focuses on the end user, encompassing ambulatory surgical centers, hospitals, and specialty clinics. This perspective of the segmentation strategy allows for a better understanding of market demand, acquisition trends, and the unique requirements of each end user category. The interplay of these diverse segments contributes to a holistic view of current market dynamics, ensuring that every aspect from technological innovation to clinical application is captured in the overall assessment. This nuanced framework is essential for stakeholders looking to strategize in a competitive and rapidly evolving landscape.

Based on Device Type, market is studied across Guidewires, Lithotripters, Stents, and Ureteroscopes.

Based on Treatment Type, market is studied across Extracorporeal Shock Wave Lithotripsy, Intracorporeal Lithotripsy, and Percutaneous Nephrolithotomy.

Based on Device Material, market is studied across Metal-Based Devices and Polymer-Based Devices.

Based on Application, market is studied across Bladder Stones, Kidney Stones, and Ureteral Stones.

Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.

Regional Dynamics Shaping Global and Local Markets

The global distribution of urolithiasis management devices is significantly influenced by varying regional characteristics and healthcare infrastructure maturity. In the Americas, market growth is primarily driven by well-established healthcare systems and an increasing adoption rate of minimally invasive procedures. Regulatory frameworks in the region encourage early adoption of innovative technologies, thereby setting the stage for sustained market growth.

Across Europe, the Middle East, and Africa, there is a noticeable trend towards gradual modernization of healthcare delivery systems. Advanced medical centers, combined with the growing emphasis on patient safety and device efficacy, have markedly contributed to regional market dynamics. Clinical adoption in these regions is enhanced by targeted initiatives aimed at improving patient outcomes and reducing post-procedural complications. The diversity of healthcare systems within these areas presents both challenges and opportunities, requiring tailored strategic responses from manufacturers and service providers.

Meanwhile, the Asia-Pacific region is emerging as one of the fastest-growing markets for urolithiasis management devices. Rising healthcare expenditures, expanding infrastructure, and a surge in medical tourism are key factors driving market evolution. The blend of traditional practices with modern medical innovation creates a fertile ground for advanced device adoption. Furthermore, this region has seen significant improvements in access to specialized healthcare services, facilitating the integration of new technological advancements into current clinical practices. Together, these regional insights underscore a global scenario where local demand, regulatory policies, and infrastructure readiness collectively shape market trajectories.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Innovators in the Urolithiasis Device Sphere

The competitive landscape in the urolithiasis management device market is characterized by contributions from several leading innovators who have significantly influenced both technological advancement and market penetration. Industry pioneers such as Advanced MedTech Holdings have consistently set benchmarks through extensive research and development initiatives. Similarly, companies like AKSM, Ltd. and Avvio Medical, Inc. are making remarkable strides in designing devices that cater to highly specialized clinical requirements, while Becton, Dickinson and Company alongside Boston Scientific Corporation are leveraging their global footprint to drive widespread acceptance of novel treatment methodologies.

Other key players including Calyxo Inc. and Coloplast A/S have focused on enhancing device ergonomics and integrating user-centric functionalities to ensure seamless operation during surgical procedures. Cook Group Incorporated and DirexGroup bring a strategic blend of technological innovation and robust distribution networks that position them as reliable partners in the market. Additionally, Dornier MedTech GmbH, Dyne Medical Group Inc., and E.M.S. Electro Medical Systems S.A. have been pivotal in pushing the boundaries of device precision and patient safety.

EDAP TMS SA, Elmed Lithotripsy Systems, EndoTheia, Inc., and Karl Storz GmbH & Co. KG are also at the forefront of transformative developments in this sector. The contributions from innovators such as Nissha Medical Technologies, Olympus Corporation, Quanta System S.p.A., Richard Wolf GmbH, Siemens Healthineers, SonoMotion, and Teleflex Incorporated illustrate the market's evolving nature. Each of these companies has embraced a forward-thinking approach that not only enhances device functionality but also aligns with the latest trends in patient-centered care. Their collective efforts have led to significant improvements in device reliability, user experience, and clinical outcomes, positioning the industry for long-term growth.

The report delves into recent significant developments in the Urolithiasis Management Devices Market, highlighting leading vendors and their innovative profiles. These include Advanced MedTech Holdings, AKSM, Ltd., Avvio Medical, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Calyxo Inc., Coloplast A/S, Cook Group Incorporated, DirexGroup, Dornier MedTech GmbH, Dyne Medical Group Inc., E.M.S. Electro Medical Systems S.A., EDAP TMS SA, Elmed Lithotripsy Systems, EndoTheia, Inc., Karl Storz GmbH & Co. KG, Nissha Medical Technologies, Olympus Corporation, Quanta System S.p.A., Richard Wolf GmbH, Siemens Healthineers, SonoMotion, and Teleflex Incorporated. Guiding Strategic Recommendations for Market Excellence

Industry stakeholders need to adopt a multi-faceted strategy to maintain a competitive edge in the evolving market of urolithiasis management devices. One of the first actionable recommendations is to ensure ongoing investment in research and development, particularly in areas that enhance device precision and improve patient safety. Stakeholders should collaborate closely with clinical research bodies to ensure that new products not only meet regulatory standards but also align with the evolving needs of the healthcare market.

Another key recommendation is to strengthen partnerships across the value chain, ranging from raw material suppliers to healthcare practitioners who deploy these devices in clinical settings. Effective collaboration can facilitate the integration of digital technologies and analytics, allowing companies to streamline operations and develop devices that deliver both cost efficiency and enhanced procedural outcomes. It is also advisable for manufacturers to remain agile in response to regional variations in market dynamics; tailoring strategies for different geographies by understanding local regulatory environments, healthcare priorities, and patient demographics can yield significant competitive advantages.

Moreover, companies should focus on training and support programs that empower clinical teams to fully leverage the benefits of advanced urolithiasis management technology. Emphasizing continuous education, workshops, and real-world case demonstrations can boost confidence among users and accelerate the adoption curve. Strategic investments in digital marketing and thought leadership are also critical in establishing a strong brand presence and influencing decision-makers in the healthcare sector. By adopting these recommendations, industry leaders can not only secure their market position but also drive transformative changes that resonate across clinical practices worldwide.

Concluding Reflections on Market Trends and Future Prospects

In conclusion, the current market for urolithiasis management devices is set on a promising path, driven by significant technological advancements and an increasing emphasis on minimally invasive procedures. The strategic integration of innovations, ranging from advanced imaging to digital analytics, has fundamentally altered the approach to managing urolithiasis. As stakeholders navigate this dynamic environment, a deep understanding of market segmentation, regional dynamics, and competitive forces remains critical.

The insights gathered from both qualitative and quantitative analyses suggest that market players must continue to invest in product development and embrace collaborative partnerships to meet the rising expectations of healthcare providers. The future of urolithiasis management is not solely reliant on isolated technological innovations but also on the seamless integration of these advancements within existing clinical infrastructures. As global healthcare demands evolve, businesses that maintain a patient-centric approach, focus on reliability, and adapt swiftly to market changes are likely to thrive.

The continuous evolution in this industry will undoubtedly usher in further developments that may set new standards for efficiency and efficacy in patient care. As medical professionals, researchers, and device manufacturers build on the current momentum, the overall impact on patient outcomes could be transformative. Ultimately, the convergence of innovation, strategic investments, and a comprehensive understanding of market dynamics will drive the future success and sustainability of the urolithiasis management device sector.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of urinary stones and increasing elderly population
      • 5.1.1.2. Rising proclivity for non-invasive surgeries and awareness of minimally invasive techniques
      • 5.1.1.3. Increasing adoption of innovative technologies in the hospital sector
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability and high cost of urolithiasis devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of portable and user-friendly urolithiasis management devices
      • 5.1.3.2. Technological advancements in minimally invasive devices for effective urolithiasis treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns over probable side effects of the treatment
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device Type: Rising preference for ureteroscopes owing to visual and mechanical excellence in stone extraction
    • 5.2.2. Application: Expanding application of urolithiasis management devices for bladder stone management
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Urolithiasis Management Devices Market, by Device Type

  • 6.1. Introduction
  • 6.2. Guidewires
  • 6.3. Lithotripters
  • 6.4. Stents
  • 6.5. Ureteroscopes

7. Urolithiasis Management Devices Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Extracorporeal Shock Wave Lithotripsy
  • 7.3. Intracorporeal Lithotripsy
  • 7.4. Percutaneous Nephrolithotomy

8. Urolithiasis Management Devices Market, by Device Material

  • 8.1. Introduction
  • 8.2. Metal-Based Devices
  • 8.3. Polymer-Based Devices

9. Urolithiasis Management Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Bladder Stones
  • 9.3. Kidney Stones
  • 9.4. Ureteral Stones

10. Urolithiasis Management Devices Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Hospitals
  • 10.4. Specialty Clinics

11. Americas Urolithiasis Management Devices Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Urolithiasis Management Devices Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Urolithiasis Management Devices Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Nissha and Endotheia unveil FlexStone Basket, enhancing kidney stone removal through innovation and collaboration
    • 14.3.2. FDA de novo clearance granted to Stone Clear, a non-invasive device for managing post-lithotripsy kidney stones and reducing relapse risk
    • 14.3.3. Olympus enhances urolithiasis management with FDA-cleared RenaFlex single-use flexible ureteroscope
    • 14.3.4. Calyxo receives FDA approval for redesign of device that collects kidney stone fragments
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced MedTech Holdings
  • 2. AKSM, Ltd.
  • 3. Avvio Medical, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Boston Scientific Corporation
  • 6. Calyxo Inc.
  • 7. Coloplast A/S
  • 8. Cook Group Incorporated
  • 9. DirexGroup
  • 10. Dornier MedTech GmbH
  • 11. Dyne Medical Group Inc.
  • 12. E.M.S. Electro Medical Systems S.A.
  • 13. EDAP TMS SA
  • 14. Elmed Lithotripsy Systems
  • 15. EndoTheia, Inc.
  • 16. Karl Storz GmbH & Co. KG
  • 17. Nissha Medical Technologies
  • 18. Olympus Corporation
  • 19. Quanta System S.p.A.
  • 20. Richard Wolf GmbH
  • 21. Siemens Healthineers
  • 22. SonoMotion
  • 23. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. UROLITHIASIS MANAGEMENT DEVICES MARKET MULTI-CURRENCY
  • FIGURE 2. UROLITHIASIS MANAGEMENT DEVICES MARKET MULTI-LANGUAGE
  • FIGURE 3. UROLITHIASIS MANAGEMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 4. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. UROLITHIASIS MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. UROLITHIASIS MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. UROLITHIASIS MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. UROLITHIASIS MANAGEMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETEROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY METAL-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY POLYMER-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY BLADDER STONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY KIDNEY STONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETERAL STONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. UROLITHIASIS MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 237. UROLITHIASIS MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024